US Patent No. 8,980,638

Use of IMP3 as a prognostic marker for cancer
Apr 24, 2015

University of Massachusetts has been awarded US Patent No. 8,980,638, "Use of IMP3 as a prognostic marker for cancer."

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Sponsored by

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.